186 related articles for article (PubMed ID: 27115324)
1. Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases.
Ganesan V; Ascherman DP; Minden JS
Biomol Concepts; 2016 May; 7(2):133-43. PubMed ID: 27115324
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.
Vazquez SE; Ferré EM; Scheel DW; Sunshine S; Miao B; Mandel-Brehm C; Quandt Z; Chan AY; Cheng M; German M; Lionakis M; DeRisi JL; Anderson MS
Elife; 2020 May; 9():. PubMed ID: 32410729
[TBL] [Abstract][Full Text] [Related]
3. Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis.
Liu J; Xing X; Huang H; Jiang Y; He H; Xu X; Yuan J; Zhou L; Yang L; Zhuang Z
Toxicol Appl Pharmacol; 2009 Nov; 240(3):393-400. PubMed ID: 19647757
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases.
Ohyama K; Baba M; Tamai M; Aibara N; Ichinose K; Kishikawa N; Kawakami A; Kuroda N
Clin Biochem; 2015 Feb; 48(3):181-5. PubMed ID: 25438073
[TBL] [Abstract][Full Text] [Related]
5. Immune response to chemically modified proteome.
Bhat S; Mary S; Banarjee R; Giri AP; Kulkarni MJ
Proteomics Clin Appl; 2014 Feb; 8(1-2):19-34. PubMed ID: 24375944
[TBL] [Abstract][Full Text] [Related]
6. [Screening for Potential Drug Targets by Comprehensive Identification of Disease-specific Antigens Incorporated into Immune Complexes in Patients with Immunological Diseases].
Ohyama K
Yakugaku Zasshi; 2016; 136(2):157-61. PubMed ID: 26831786
[TBL] [Abstract][Full Text] [Related]
7. Identifying autoantigens as theranostic targets: antigen arrays and immunoproteomics approaches.
Tassinari OW; Caiazzo RJ; Ehrlich JR; Liu BC
Curr Opin Mol Ther; 2008 Apr; 10(2):107-15. PubMed ID: 18386222
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
9. Autoantigen discovery with a synthetic human peptidome.
Larman HB; Zhao Z; Laserson U; Li MZ; Ciccia A; Gakidis MA; Church GM; Kesari S; Leproust EM; Solimini NL; Elledge SJ
Nat Biotechnol; 2011 May; 29(6):535-41. PubMed ID: 21602805
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA).
Beutgen VM; Perumal N; Pfeiffer N; Grus FH
Front Immunol; 2019; 10():381. PubMed ID: 30899261
[TBL] [Abstract][Full Text] [Related]
11. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays.
Gupta S; Manubhai KP; Mukherjee S; Srivastava S
Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches to profiling the humoral immune response and identifying disease-associated antigens.
Ohyama K; Kuroda N
Biol Pharm Bull; 2012; 35(9):1409-12. PubMed ID: 22975488
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
Simpkins F; Czechowicz JA; Liotta L; Kohn EC
Pharmacogenomics; 2005 Sep; 6(6):647-53. PubMed ID: 16143004
[TBL] [Abstract][Full Text] [Related]
14. Use of proteomics in analysis of autoimmune diseases.
Xiang Y; Kato T
Lupus; 2006; 15(7):431-5. PubMed ID: 16898178
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteomics Methods and Techniques.
Fulton KM; Baltat I; Twine SM
Methods Mol Biol; 2019; 2024():25-58. PubMed ID: 31364041
[TBL] [Abstract][Full Text] [Related]
16. Classical Immunoproteomics: Serological Proteome Analysis (SERPA) for Antigen Identification.
Fulton KM; Ananchenko A; Wolfraim L; Martin S; Twine SM
Methods Mol Biol; 2019; 2024():59-78. PubMed ID: 31364042
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq.
Vazquez SE; Mann SA; Bodansky A; Kung AF; Quandt Z; Ferré EMN; Landegren N; Eriksson D; Bastard P; Zhang SY; Liu J; Mitchell A; Proekt I; Yu D; Mandel-Brehm C; Wang CY; Miao B; Sowa G; Zorn K; Chan AY; Tagi VM; Shimizu C; Tremoulet A; Lynch K; Wilson MR; Kämpe O; Dobbs K; Delmonte OM; Bacchetta R; Notarangelo LD; Burns JC; Casanova JL; Lionakis MS; Torgerson TR; Anderson MS; DeRisi JL
Elife; 2022 Oct; 11():. PubMed ID: 36300623
[TBL] [Abstract][Full Text] [Related]
18. Phage Immunoprecipitation Sequencing of Autoantigens in Autoimmune Retinopathy.
Davoudi S; Ahmadi T; Papavasilieou E; Leskov I; Sobrin L
Ocul Immunol Inflamm; 2018; 26(3):417-424. PubMed ID: 27726466
[TBL] [Abstract][Full Text] [Related]
19. Selective, sensitive and comprehensive detection of immune complex antigens by immune complexome analysis with papain-digestion and elution.
Aibara N; Kamohara C; Chauhan AK; Kishikawa N; Miyata Y; Nakashima M; Kuroda N; Ohyama K
J Immunol Methods; 2018 Oct; 461():85-90. PubMed ID: 30158077
[TBL] [Abstract][Full Text] [Related]
20. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases.
Moritz CP; Paul S; Stoevesandt O; Tholance Y; Camdessanché JP; Antoine JC
Autoimmun Rev; 2020 Feb; 19(2):102450. PubMed ID: 31838165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
